BiotechTube

Saracatinib + Placebo Oral Tablet

Phase 1UNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Parkinson Disease Psychosis

Conditions

Parkinson Disease Psychosis

Trial Timeline

Apr 11, 2019 → Sep 1, 2021

NCT ID
NCT03661125

About Saracatinib + Placebo Oral Tablet

Saracatinib + Placebo Oral Tablet is a phase 1 stage product being developed by AstraZeneca for Parkinson Disease Psychosis. The current trial status is unknown. This product is registered under clinical trial identifier NCT03661125. Target conditions include Parkinson Disease Psychosis.

What happened to similar drugs?

20 of 20 similar drugs in Parkinson Disease Psychosis were approved

Approved (20) Terminated (3) Active (0)
✅Mirabegron + PlaceboAstellas PharmaApproved
✅Lemborexant + placeboEisaiApproved
✅Safinamide MesilateEisaiApproved
✅Istradefylline PillKyowa KirinApproved
✅Levodopa-carbidopa intestinal gel (LCIG)AbbVieApproved
✅Carbidopa/levodopa/entacaponeNovartisApproved
✅Carbidopa/levodopa/entacapone + Immediate release carbidopa/levodopaNovartisApproved

Hype Score Breakdown

Clinical
6
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03661125Phase 1UNKNOWN

Competing Products

20 competing products in Parkinson Disease Psychosis

See all competitors
ProductCompanyStageHype Score
exidavnemab + Placebo ComparatorBioArctic ABPhase 2
36
UB-312 + PlaceboVaxxinityPhase 1
19
NAV5001 + DaTscanNavidea BiopharmaceuticalsPhase 3
22
LY4006896 + PlaceboEli LillyPhase 1
36
ATH-1017 + PlaceboLeonaBioPhase 2
17
piclozotan + 0.9% sodium chloride (normal saline)Daiichi SankyoPhase 2
35
Mirabegron + PlaceboAstellas PharmaApproved
43
E2007EisaiPhase 3
32
ARICEPTEisaiPhase 3
40
PerampanelEisaiPhase 3
32
GPI 1485EisaiPhase 2
35
E2007EisaiPhase 3
40
Prior Donepezil 5mg + Prior Donzepezil 10mg + Prior PlaceboEisaiPhase 3
40
Equfina 50 mgEisaiPre-clinical
26
EqufinaEisaiPre-clinical
26
perampanel + placeboEisaiPhase 2
27
Lemborexant + placeboEisaiApproved
50
Placebo + E2007 + E2007EisaiPhase 3
32
Safinamide MesilateEisaiApproved
43
E2007 + E2007 + E2007EisaiPhase 2
35